¥1.49
+
¥0.02 (1.34%)
End-of-day quote: 05/10/2024
SHSE:600165
Ningxia Zhongke Biotechnology Annual Report
| Year | Year | 2016 | 2014 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
¥2.79B | ¥1.34B | ¥1.84B | ¥1.68B | |
| GM % | Gross Margin % |
|
3.55% | 3.45% | 10.15% | 10.57% | |
| OM | Operating Margin |
|
-4.89% | -8.91% | 2.40% | 1.89% | |
| EPS | Earnings Per Share |
|
¥0.00 | ¥-0.29 | ¥-0.30 | ¥0.01 | ¥-0.02 |
| Div. | Dividends |
|
¥0.00 | ¥0.00 | ¥0.00 | ¥0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
684.88m | 684.88m | 684.88m | 684.88m | |
| OCF | Operating Cash Flow |
|
¥-191.05M | ¥-241.90M | ¥100.11M | ¥-191.62M | |
| FCF | Free Cash Flow |
|
¥-200.41M | ¥-266.31M | ¥-172.52M | ¥-254.81M | |
| FCFS | Free Cash Flow Per Share |
|
¥-0.29 | ¥-0.39 | ¥-0.25 | ¥-0.44 |
